Cannabix Technologies Inc
Cannabix Technologies Inc., a technology company, develops marijuana and alcohol breathalyzer technologies for employers, law enforcement, workplaces, and laboratories in the United States. It offers Cannabix Marijuana Breath Test (MBT) for Tetrahydrocannabinol (THC) detection and quantification; Cannabix breath collection unit and breath cartridge for human breath sample collection, storage, and… Read more
Cannabix Technologies Inc (BLOZF) - Net Assets
Latest net assets as of October 2025: $1.87 Million USD
Based on the latest financial reports, Cannabix Technologies Inc (BLOZF) has net assets worth $1.87 Million USD as of October 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($2.17 Million) and total liabilities ($304.66K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $1.87 Million |
| % of Total Assets | 85.99% |
| Annual Growth Rate | 28.87% |
| 5-Year Change | -75.23% |
| 10-Year Change | -60.24% |
| Growth Volatility | 564.32 |
Cannabix Technologies Inc - Net Assets Trend (2012–2025)
This chart illustrates how Cannabix Technologies Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Cannabix Technologies Inc (2012–2025)
The table below shows the annual net assets of Cannabix Technologies Inc from 2012 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-04-30 | $2.55 Million | -42.69% |
| 2024-04-30 | $4.45 Million | -33.66% |
| 2023-04-30 | $6.71 Million | -22.34% |
| 2022-04-30 | $8.64 Million | -16.13% |
| 2021-04-30 | $10.30 Million | +19.16% |
| 2020-04-30 | $8.64 Million | -39.74% |
| 2019-04-30 | $14.34 Million | -3.84% |
| 2018-04-30 | $14.92 Million | +100.55% |
| 2017-04-30 | $7.44 Million | +15.93% |
| 2016-04-30 | $6.42 Million | +28.83% |
| 2015-04-30 | $4.98 Million | +2112.56% |
| 2014-04-30 | $225.09K | +311.51% |
| 2013-04-30 | $54.70K | -42.04% |
| 2012-04-30 | $94.37K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Cannabix Technologies Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 4191400800.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (April 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $34.16 Million | 1338.79% |
| Other Components | $10.53 Million | 412.76% |
| Total Equity | $2.55 Million | 100.00% |
Cannabix Technologies Inc Competitors by Market Cap
The table below lists competitors of Cannabix Technologies Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Mawson Finland LImited
V:MFL
|
$47.29 Million |
|
Jaiprakash Associates Limited
NSE:JPASSOCIAT
|
$47.30 Million |
|
Woosu AMS Co.Ltd
KQ:066590
|
$47.31 Million |
|
Byuksan Corp
KO:007210
|
$47.32 Million |
|
Jindal Drilling And Industries Limited
NSE:JINDRILL
|
$47.28 Million |
|
Lea Bank ASA
OL:LEA
|
$47.28 Million |
|
D O Green Technologies Bhd
KLSE:7204
|
$47.28 Million |
|
Drilling Tools International Corp.
NASDAQ:DTI
|
$47.28 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Cannabix Technologies Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 4,451,308 to 2,551,197, a change of -1,900,111 (-42.7%).
- Net loss of 4,686,316 reduced equity.
- Other comprehensive income decreased equity by 8,632,443.
- Other factors increased equity by 11,418,648.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-4.69 Million | -183.69% |
| Other Comprehensive Income | $-8.63 Million | -338.37% |
| Other Changes | $11.42 Million | +447.58% |
| Total Change | $- | -42.69% |
Book Value vs Market Value Analysis
This analysis compares Cannabix Technologies Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 18.95x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 44.51x to 18.95x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2012-04-30 | $0.01 | $0.42 | x |
| 2013-04-30 | $0.01 | $0.42 | x |
| 2014-04-30 | $0.03 | $0.42 | x |
| 2015-04-30 | $0.12 | $0.42 | x |
| 2016-04-30 | $0.10 | $0.42 | x |
| 2017-04-30 | $0.09 | $0.42 | x |
| 2018-04-30 | $0.16 | $0.42 | x |
| 2019-04-30 | $0.14 | $0.42 | x |
| 2020-04-30 | $0.08 | $0.42 | x |
| 2021-04-30 | $0.10 | $0.42 | x |
| 2022-04-30 | $0.08 | $0.42 | x |
| 2023-04-30 | $0.06 | $0.42 | x |
| 2024-04-30 | $0.04 | $0.42 | x |
| 2025-04-30 | $0.02 | $0.42 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Cannabix Technologies Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -183.69%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 1.18x
- Recent ROE (-183.69%) is below the historical average (-88.00%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2012 | -233.20% | 0.00% | 0.00x | 1.02x | $-229.51K |
| 2013 | -143.12% | 0.00% | 0.00x | 1.64x | $-83.75K |
| 2014 | -223.64% | 0.00% | 0.00x | 1.36x | $-525.92K |
| 2015 | -35.52% | 0.00% | 0.00x | 1.01x | $-2.27 Million |
| 2016 | -14.29% | 0.00% | 0.00x | 1.00x | $-1.56 Million |
| 2017 | -50.18% | 0.00% | 0.00x | 1.02x | $-4.48 Million |
| 2018 | -9.84% | 0.00% | 0.00x | 1.01x | $-2.96 Million |
| 2019 | -27.05% | 0.00% | 0.00x | 1.01x | $-5.31 Million |
| 2020 | -80.64% | 0.00% | 0.00x | 1.01x | $-7.84 Million |
| 2021 | -89.74% | -140.60% | 0.63x | 1.01x | $-10.27 Million |
| 2022 | -38.98% | 0.00% | 0.00x | 1.01x | $-4.23 Million |
| 2023 | -31.87% | 0.00% | 0.00x | 1.04x | $-2.81 Million |
| 2024 | -70.24% | 0.00% | 0.00x | 1.06x | $-3.57 Million |
| 2025 | -183.69% | 0.00% | 0.00x | 1.18x | $-4.94 Million |
Industry Comparison
This section compares Cannabix Technologies Inc's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $694,749,556
- Average return on equity (ROE) among peers: -25.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Cannabix Technologies Inc (BLOZF) | $1.87 Million | -233.20% | 0.16x | $47.28 Million |
| Advanced Biomedical Technologies Inc (ABMT) | $-4.46 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $191.37 Billion |
| Acarix AB (publ) (ACIXF) | $1.93 Million | -127.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $4.05 Million |
| Adm Tronics Unltd (ADMT) | $-12.69K | 0.00% | 0.00x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $-3.07 Million | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $732.88K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $914.25 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $9.18 Million |